This web site uses cookies to deliver its users personalized dynamic content. You are hereby informed that cookies are necessary for the web site's functioning and that by continuing to use this web sites, cookies will be used in cooperation with your Web browser.
There is increasing concern over new emerging diseases threatening animal and human health. The source of many of these infections is wildlife populations, both within the EU and elsewhere. To address this problem our consortium aims to develop a comprehensive system of surveillance of wild animal diseases relevant to European public and animal health. We will develop cutting edge molecular and serological technologies for the detection of existing and new emerging infectious agents in wild animal populations. The particular strength of this technology is that it will enable, for the first time, simultaneous screening of individual samples for a wide range of pathogens. The results will be used to evaluate patterns of disease spread, to detect new and evolving pathogens, and to assess the risks associated with these changes. This information will be used to reduce the risk of and potentially prevent further epidemics. We will develop a fully accessible data base for wild animal infections both arising from this project and from other world-wide networks. This will enable us to construct a pan-European surveillance framework for wildlife diseases using effective and affordable technology. The WildTech consortium, with its Associate Partners (APs), has the potential to significantly impact a broad range of human and animal health and welfare issues in the long term. Within the four year term of the project, our aims are to demonstrate the value of new technologies for disease surveillance and epidemiology to international organisations which have responsibility for monitoring and coordinating control of animal disease and public health (particularly the OIE). Surveillance and management of wildlife disease in Europe and elsewhere in the world will increasingly become an activity that will be integrated with animal health, public health and wildlife organisations. The strengths of our consortium are (i) cutting edge technologies involving several laboratories which are international experts in these fields, (ii) integration of existing laboratories and research groups with wildlife expertise into the project through the Associate Partners (iii) integration of infection incidence data with epidemiological analysis and risk assessment which will be a vital component of any disease management system developed by the OIE, (iv) close collaboration with international organisations, including the OIE and the existing Networks of Excellence (Epizone and MedVetNet), (v) extensive contacts with US and Canadian wildlife disease organisations, (vi) integration of the outcomes into existing and fully accessible wildlife disease web sites.
Short description of the task performed by Croatian partner
Integration of infection incidence data with epidemiological analysis and risk assessment which will be a vital component of any disease management system developed by the OIE; Close collaboration with international organisations, including the OIE and the existing Networks of Excellence (Epizone and MedVetNet); Extensive contacts with US and Canadian wildlife disease organizations; Integration of the outcomes into existing and fully accessible wildlife disease web sites.